Markets:

Overview

News

Currencies

International

Treasuries

GH Research PLC - Ordinary Shares (NQ:GHRS)

14.07 +0.68 (+5.12%)

Streaming Delayed Price Updated: 1:16 PM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GH Research PLC - Ordinary Shares

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Psychedelic Stock Gainers And Losers From February 9, 2022 ↗

February 09, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 14.29% at $5.76

Via Benzinga

Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today ↗

February 08, 2022

GAINERS: Awakn Life Sciences (OTC:AWKNF) shares closed up 3.51% at $1.62

Via Benzinga

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗

February 07, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 9.82% at $1.23

Via Benzinga

Psychedelic Stocks Finally In An Upswing ↗

February 06, 2022

The Marijuana & Psychedelic Compounds-Based Drug Stocks Index went up +5.3% last week.

Via Talk Markets

Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today ↗

February 04, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.29% at $0.20

Via Benzinga

Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

February 03, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.29% at $0.19

Via Benzinga

Mind Medicine, Allied Among Top Psychedelic Movers Of Today ↗

February 02, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 5.04% at $0.17

Via Benzinga

New Psychedelics ETF Launches On NYSE Arca ↗

February 02, 2022

Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)...

Via Benzinga

Mindset Pharma, Allied Among Top Psychedelic Movers Of Today ↗

February 01, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 15.70% at $0.69

Via Benzinga

ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗

January 31, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.89% at $5.33

Via Benzinga

The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January ↗

January 30, 2022

This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.

Via Talk Markets

Psychedelic Stock Gainers And Losers From January 28, 2022 ↗

January 28, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 17.86% at $0.57

Via Benzinga

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗

January 27, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 6.29% at $0.49

Via Benzinga

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗

January 26, 2022

GAINERS: Small Pharma (OTC:

Via Benzinga

Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today ↗

January 25, 2022

GAINERS: Mind Medicine (NASDAQ:

Via Benzinga

Psychedelic Stock Gainers And Losers From January 24, 2022 ↗

January 24, 2022

GAINERS: Field Trip Health (NASDAQ:

Via Benzinga

Top Ideas in the Small Cap Biotech Space (LEXTF, ABBV, SAVA, SNDL, RETA, PAHC)

January 24, 2022

Via AB Newswire

Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD ↗

January 23, 2022

This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a...

Via Talk Markets

Psychedelic Stock Gainers And Losers From January 21, 2022 ↗

January 21, 2022

GAINERS: GH Research (NASDAQ:

Via Benzinga

Psychedelic Stock Gainers And Losers From January 20, 2022 ↗

January 20, 2022

GAINERS: Small Pharma (OTC:

Via Benzinga

Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗

January 19, 2022

GAINERS: Revive Therapeutics (OTC:

Via Benzinga

Psychedelic Stock Gainers And Losers From January 18, 2022 ↗

January 18, 2022

GAINERS: Cybin (AMEX:

Via Benzinga

Year-End Summary: Marijuana & Psychedelic Compounds-Based Drug Stocks Index Went DOWN -33.6% In 2021! ↗

January 02, 2022

Which index performed the best in 2021, the Marijuana Drug Stocks Index, or the Psychedelic Compounds-Based Drug Stocks Index? Which constituents contributed to their performances? This article has the...

Via Talk Markets

Steep Decline In Cannabis & Psychedelic Compounds-Based Drug Stocks Continues: DOWN -16.6% MTD ↗

December 24, 2021

All 12 constituents in the Marijuana & Psychedelic Compounds-Based Drug Stocks Index continue to decline. How do their performances compare month-to-date and YTD?

Via Talk Markets

56 Biggest Movers From Friday ↗

January 10, 2022

Gainers Hour Loop, Inc. (NASDAQ: HOUR) shares jumped 99.8% to $7.99 after the company priced its IPO at $4 per share. China HGS Real Estate Inc. (NASDAQ: HGSH) shares...

Via Benzinga

The Year In Review For Psychedelic Drug Stocks: 2021 ↗

December 21, 2021

2021 was two different

Via Talk Markets

Cannabis & Psychedelic Compound-Based Drug Stocks Continue To Decline ↗

December 12, 2021

The six marijuana-based clinical-stage stocks are down 31.1% since the end of June; the 9 psychedelic compound-based clinical-stage stocks with market caps under $1B are down 36.3% in that same...

Via Talk Markets

Topics Cannabis

60 Biggest Movers From Yesterday ↗

December 07, 2021

Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore...

Via Benzinga

GH Research Announces Positive Trial Results For Treatment-Resistant Depression ↗

December 06, 2021

Clinical-stage biopharmaceutical company GH Research PLC (NASDAQ: GHRS) announced positive results from recent clinical trials of its leading 5-MeO-DMT formula, a therapy...

Via Benzinga

GH Research Posts Data From Treatment-Resistant Depression Trial ↗

December 06, 2021

GH Research PLC (NASDAQ: GHRS) has reported the outcome of the Phase 2 part of a Phase 1/2 trial of GH001, an inhalable 5-MeO-DMT product candidate for treatment-...

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.